Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients - sprookjes - yvandenbroek - TriplyDB

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

http://www.wikidata.org/entity/Q27480744

about

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles.Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.HLA-Cw*04 and hepatitis C virus persistence.Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers Interferon-gamma is produced by CD8+ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment Cellular immune responses against hepatitis C virus: the evidence base 2002 Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers Acute hepatitis C virus infection: A chronic problem Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCV Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization Analysis of successful immune responses in persons infected with hepatitis C virus Influence of host resistance on viral adaptation: hepatitis C virus as a case study Determinants of viral clearance and persistence during acute hepatitis C virus infection The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels Genomic analysis of the host response to hepatitis B virus infection.Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction.CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response Hepatitis C virus mutation affects proteasomal epitope processing Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in China Enhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma.Specific gut commensal flora locally alters T cell tuning to endogenous ligands.Immune responses during acute and chronic infection with hepatitis C virus.Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.The size of the viral inoculum contributes to the outcome of hepatitis B virus infection.

P2860

Q24290542-7CB493F2-3468-43FE-B35E-F61C1FF2D4FE Q24653498-B875DA5E-B554-4092-9BDB-094D364FC393 Q27469524-D9E83E4F-A44B-4D23-83CD-C1C0AC8B1E72 Q27469551-6B5BF158-F1DC-444A-9C0E-41EBC45532F0 Q27469577-453B80CB-B18B-4390-872E-D1CCDDBCD541 Q27469642-C7A038AB-FBFD-4DF8-8D1B-316A96FBE194 Q27469698-EB8C5189-50E7-4C36-89D7-0FC069C528D2 Q27469764-39F64594-94D6-46E9-9264-F5251B568265 Q27469883-D618B3E1-A909-4BC9-9B54-FE4B3F0C2DD1 Q27472874-3D623868-FA04-48D8-B6D4-8D54231B4E38 Q27472879-C671E372-F596-4E1D-AA02-15CAAFDDC08E Q27472881-E37A081C-D72A-4E21-9B7C-BAC68CD062C3 Q27473001-EB1B9179-9F17-4FA4-ABC5-4B616BF7D338 Q27477753-9D07EB36-1464-4634-8669-DC197E0DBF97 Q27478124-C606F9B7-15AF-4BF7-826D-8240792DE444 Q27480426-A9CC3271-A07B-4DE8-9B4C-45E2AD1EE0A6 Q27480725-683E0B00-BFF7-4F1C-8504-45FDBEE665D9 Q27480734-2CCE688D-988F-462C-87CB-9B9D1F55973C Q27485114-31ED55C3-15F3-4CC8-BC40-75E6D4F85780 Q27485639-7DC4CA80-321B-43DA-B463-B20237A9D795 Q27486579-FAF3CF17-B80D-4E18-8BBC-0858EF1B5C13 Q27488289-EDEA584C-BBCA-4AC9-9216-264D7F10B783 Q27860698-D6F3011B-CE0B-4D50-B4C9-1B0FCF9CAA9D Q28087595-363FDFD2-DEF2-4432-B34A-5F7CBA6424A6 Q28131757-5CEE3666-7C39-49BB-926B-C55EF361DE2E Q28344154-B1459A94-C630-46F5-ADCE-F02B3C99C89E Q33696514-C9F6940C-99C6-4027-A6C2-276F0ECFD319 Q33973907-53F3147D-30D1-46DE-BA0D-EB07AFF88D53 Q34151071-8138EB16-C351-44B7-9EB4-7F636759831B Q34235321-E938D7EB-83F0-4F3B-B35B-1F1FAF2BD4D9 Q34390492-F46408BA-5787-4369-9125-1702C0BA31EF Q34462354-E14DCE90-64EF-47CE-B7B3-ECBDF69F7589 Q34552781-0B1B69EE-7CC6-4F8D-8631-B3003052A968 Q35835376-5D508D37-9881-402E-BF1B-47151AAC1DEA Q36178576-F8891C7B-D8B9-4D0B-919F-8FCCF6A7552E Q36334405-6B726A5F-7A1A-4F6D-AAD3-F0B4A88413E6 Q37108927-D280124E-95B6-4C01-9D75-F9012D66F1FD Q37178225-A9FCCBEF-A42C-4795-ADE3-A487BCCA92CC Q37349027-2CDA50E8-3389-4855-8D68-99F0542CE84C Q37356013-BB1E926C-5E45-4095-98A5-B9F7D4D258FE

P2860

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

http://www.wikidata.org/entity/Q27480744

description

1996 nî lūn-bûn

@nan

1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Differential cytotoxic T-lymph ...... chronically infected patients

@ast

Differential cytotoxic T-lymph ...... chronically infected patients

@en

Differential cytotoxic T-lymph ...... chronically infected patients

@nl

type

label

Differential cytotoxic T-lymph ...... chronically infected patients

@ast

Differential cytotoxic T-lymph ...... chronically infected patients

@en

Differential cytotoxic T-lymph ...... chronically infected patients

@nl

prefLabel

Differential cytotoxic T-lymph ...... chronically infected patients

@ast

Differential cytotoxic T-lymph ...... chronically infected patients

@en

Differential cytotoxic T-lymph ...... chronically infected patients

@nl

P1433

Q27480744-EE86E400-17D1-4E03-8FD4-A11356E4CAC0

P1476

Q27480744-C8ACE3FA-467A-4FF8-A673-48D9CDC497AA

P2093

Q27480744-45E676D1-259C-4D8D-97C2-9AC8D063C62A

Q27480744-5A599DA0-6923-4AEE-90C3-6415A0AA5449

Q27480744-72B3EF22-431E-4FAA-BCCF-72F8D7793A8A

Q27480744-96DCF28E-786A-4C32-A143-E3D7973878B7

Q27480744-A78FDD0A-B803-4AB8-8C62-6CA3682425EE

Q27480744-D5B145F6-5CA8-413A-AC2B-41D38266F193

Q27480744-F4999EE4-C7EA-411C-953B-BDCB21CF0A88

P2860

Q27480744-0513C6F7-6AF6-4D01-AE78-88A257DF6F32

Q27480744-0FDC599C-5838-4E0E-A3B4-BC521D84FE2F

Q27480744-1D8D126D-D99E-4DE9-8353-878F6591683E

Q27480744-20698AF6-1905-4DCC-A6A6-CF54C831EC3F

Q27480744-25581CAF-8AC3-4748-9286-839BDCBBA444

Q27480744-27CB3009-3A33-492E-B6B2-8153278DFB6C

Q27480744-3A6337FC-C4C5-4173-83C0-D827E41FB32F

Q27480744-4B78A6E9-C175-44AA-AF6D-F788306E2745

Q27480744-5D15A9F7-4FC5-487E-8956-CAE160E41FF9

Q27480744-5D2CE8AB-4BA1-4B66-B253-0A50205C9E8A

P304

Q27480744-F91F30DD-24D0-4A62-AB52-0C355CEE5FA1

P31

Q27480744-2EEB4E51-3159-4B4C-9996-FBB13F86D82D

P433

Q27480744-D477E538-EF9B-45E2-B46D-F6F1D80245C4

P478

Q27480744-081A99E8-6F60-4C91-B1D5-977FD9F460BA

P577

Q27480744-0B568686-D4B3-4715-895A-D6D2F2247B06

P698

Q27480744-23858F80-0BB6-4BA3-8F19-D77F47CF404A

P921

Q27480744-01DD1ACB-747C-447F-9B26-BB23AFD3F33F

Q27480744-52B5129F-5ABC-4818-98A0-C90EC8A0E491

Q27480744-C8E7BD73-1B2E-4D7E-B4D7-4A474CE2C91A

P932

Q27480744-5D091A0E-291F-47EC-B9CB-89BDD2EE9A68

P1433

Journal of Virology

P1476

Differential cytotoxic T-lymph ...... chronically infected patients

@en

P2093

B Rehermann

http://www.w3.org/2001/XMLSchema#string

C M Rice

http://www.w3.org/2001/XMLSchema#string

F V Chisari

http://www.w3.org/2001/XMLSchema#string

J McHutchinson

http://www.w3.org/2001/XMLSchema#string

K M Chang

http://www.w3.org/2001/XMLSchema#string

M Houghton

http://www.w3.org/2001/XMLSchema#string

R Kokka

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

The times they are still a'changing: keeping up with the times.

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.

P304

7092-7102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

1996-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8794355

http://www.w3.org/2001/XMLSchema#string

P921

P932

190761

http://www.w3.org/2001/XMLSchema#string